Skip to content
Search

Latest Stories

Free testing ends on April 1 but healthcare workers, vulnerable to still get Covid-19 tests without charge

Britain said on Tuesday that healthcare workers, social care staff and the most vulnerable will still get Covid-19 tests without any charge when it ends free testing for the general public next month.

When he announced all coronavirus restrictions would be scrapped in February, prime minister Boris Johnson said free tests would end on April 1, saying the country could not afford their cost.


Chancellor Rishi Sunak too has insisted that it was no longer feasible for his department to spend £2 billion a month on free testing.

Health secretary Sajid Javid said people at risk of serious illness from Covid-19 would continue to get free tests if they developed symptoms, along with NHS staff (including community pharmacy teams), those working in social care and those in other high-risk jobs.

Covid cases and hospitalisations have risen in recent weeks, but the government said more than 55 per cent of those who tested positive in hospital for the virus had been admitted for other ailments.

Meanwhile, booster vaccine shots are being rolled out for older and immunosuppressed people.

From Friday, people who develop symptoms such as a high temperature or other respiratory infections will be advised to stay at home and avoid contact with other people until they feel better and no longer have a fever.

Those who test positive for Covid will be advised to stay at home for five days and avoid any contact with other people for five days.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less